Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety.
Al-Sanea MM, Gotina L, Mohamed MF, Grace Thomas Parambi D, Gomaa HAM, Mathew B, Youssif BGM, Alharbi KS, Elsayed ZM, Abdelgawad MA, Eldehna WM. Al-Sanea MM, et al. Among authors: abdelgawad ma. Drug Des Devel Ther. 2020 Feb 4;14:497-508. doi: 10.2147/DDDT.S237957. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32103894 Free PMC article.
New Sulfamethoxazole Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors: Design, Synthesis, Cytotoxic Activity and Molecular Modeling.
Abdelgawad MA, Bukhari SNA, Musa A, Elmowafy M, Elkomy MH, Nayl AA, El-Ghorab AH, Alsohaimi IH, Abdel-Bakky MS, Althobaiti IO, Altaleb HA, Omar HA, Abdelazeem AH, Zaki MA, Shaker ME, Elshemy HAH. Abdelgawad MA, et al. Pharmaceuticals (Basel). 2022 Sep 10;15(9):1134. doi: 10.3390/ph15091134. Pharmaceuticals (Basel). 2022. PMID: 36145355 Free PMC article.
The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro, and in silico mechanistic investigations.
Musa A, Ihmaid SK, Hughes DL, Said MA, Abulkhair HS, El-Ghorab AH, Abdelgawad MA, Shalaby K, Shaker ME, Alharbi KS, Alotaibi NH, Kays DL, Taylor LJ, Parambi DGT, Alzarea SI, Al-Karmalawy AA, Ahmed HEA, El-Agrody AM. Musa A, et al. Among authors: abdelgawad ma. J Biomol Struct Dyn. 2023;41(21):12411-12425. doi: 10.1080/07391102.2023.2167000. Epub 2023 Jan 20. J Biomol Struct Dyn. 2023. PMID: 36661285
Corrigendum to "Development and assessment of phospholipid-based luteolin-loaded lipid nanocapsules for skin delivery" [Int. J. Pharm. 629 (2022) 122375].
Elmowafy M, Shalaby K, Elkomy MH, Alsaidan OA, Gomaa HAM, Abdelgawad MA, Massoud D, Salama A, El-Say KM. Elmowafy M, et al. Among authors: abdelgawad ma. Int J Pharm. 2023 Mar 25;635:122782. doi: 10.1016/j.ijpharm.2023.122782. Epub 2023 Feb 27. Int J Pharm. 2023. PMID: 36858890 No abstract available.
148 results